抗体探索市場、規模、シェア、動向、産業分析レポート：方法別、抗体タイプ別、エンドユーザー別、地域別-2025～2034年市場予測

Polaris Market Researchの最新調査によると、抗体探索市場規模は2034年までに204億1,000万米ドルに達する見込みです。このレポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

抗体探索は、ウイルス、細菌、がん細胞などの標的に特異的に結合する抗体を同定し開発するプロセスです。ハイブリドーマ技術、ファージディスプレイ、単一B細胞スクリーニングなどの技術を駆使して、効果的な抗体を単離し、最適化します。これらの抗体は、診断、治療、または調査において使用される可能性があるため、特性評価され、検査されます。

個別化医療は、個人の遺伝的体質や病態に合わせた治療に焦点を当てることで、病気の治療方法を変革しています。抗体は、がん細胞に見られるような体内の特定の分子を標的とするように設計できるため、このアプローチにおいて重要な役割を果たしています。より正確で副作用の少ない治療を好む人々や医師が増えるにつれ、カスタマイズ型抗体治療への需要が高まっています。このシフトは、治療に全く同じ反応を示す患者が2人といない腫瘍学のようなセグメントで特に重要です。抗体探索技術は、異なる患者群に合わせた特異性の高い治療法の同定と開発を可能にします。この動向は、製薬会社が個別化アプローチをサポートする調査により多くの投資を行うよう促しています。個別化医療に対する認識と成功事例が増えるにつれ、抗体探索市場は前進し、将来のヘルスケアに不可欠なものとなります。

バイオテクノロジー企業、製薬大手、学術機関、ラボ間の戦略的提携は、抗体探索の進展に大きな役割を果たしています。このようなパートナーシップにより、異なる組織がリソース、知識、技術を共有し、創薬プロセスをより迅速で効果的なものにすることができます。ラボは先進的技術的セットアップを持っているかもしれないし、製薬会社は資金や製造能力を持っている可能性があります。共同研究はさらに、医薬品開発に伴う高いコストとリスクの管理にも役立ちます。現在、多くの企業が利益と責任を共有するために、共同開発やライセンス契約を結んでいます。このような動向により、臨床検査に入り、最終的に患者に届く抗体医薬品の数が増加しています。

抗体探索市場レポートハイライト

2024年には、汎用性、信頼性、比較的短時間で高親和性抗体を産生する能力から、ファージディスプレイセグメントが最大のシェアを占めます。

製薬バイオテクノロジー産業セグメントは、がん、自己免疫疾患、感染症など幅広い疾患を治療するため、モノクローナル抗体を含む生物製剤の開発にますます注力していることから、予測期間中に大きな成長が見込まれます。

2024年時点では、北米は強力な生物医療研究インフラとライフサイエンスへの一貫した投資により、抗体探索市場で最大のシェアを占めています。

アジア太平洋の抗体探索市場は、バイオテクノロジー産業の拡大、政府の支援策、ヘルスケア研究への投資の増加によって大きな成長を遂げています。

世界の主要市場参入企業は、Biocytogen、Charles River Laboratories、Creative Biolabs、Danaher Corporation、Eurofins Scientific、Evotec、Fairjourney Biologics S.A、Genscript Technology Corporation、Sartorius AG、Twist Bioscienceなどがあります。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の抗体発見市場洞察

• 市場スナップショット
• 抗体発見市場力学
  • 促進要因と機会
    • 慢性疾患と感染症の蔓延
    • バイオ医薬品研究開発への投資の増加
  • 抑制要因と課題
    • 製造の初期コストが高め
• PESTEL分析
• 抗体発見市場の動向
• バリューチェーン分析

第5章 世界の抗体発見市場：方法別

• 主要調査結果
• イントロダクション
• ファージディスプレイ
• ハイブリドーマ
• その他

第6章 世界の抗体発見市場：抗体タイプ別

• 主要調査結果
• イントロダクション
• ヒト化抗体
• ヒト抗体
• キメラ抗体
• マウス抗体

第7章 世界の抗体発見市場：エンドユーザー別

• 主要調査結果
• イントロダクション
• 製薬バイオテクノロジー産業
• ラボ
• 学術ラボ

第8章 世界の抗体発見市場：地域

• 主要調査結果
• イントロダクション
  • 抗体発見市場評価：地域、2020～2034年
• 北米
  • 北米：方法別、2020～2034年
  • 北米：抗体タイプ別、2020～2034年
  • 北米：エンドユーザー別、2020～2034年
  • 米国
  • カナダ
• 欧州
  • 欧州：方法別、2020～2034年
  • 欧州：抗体タイプ別、2020～2034年
  • 欧州：エンドユーザー別、2020～2034年
  • 英国
  • フランス
  • ドイツ
  • イタリア
  • スペイン
  • オランダ
  • ロシア
  • その他の欧州
• アジア太平洋
  • アジア太平洋：方法別、2020～2034年
  • アジア太平洋：抗体タイプ別、2020～2034年
  • アジア太平洋：エンドユーザー別、2020～2034年
  • 中国
  • インド
  • マレーシア
  • 日本
  • インドネシア
  • 韓国
  • オーストラリア
  • その他のアジア太平洋
• 中東・アフリカ
  • 中東・アフリカ：方法別、2020～2034年
  • 中東・アフリカ：抗体タイプ別、2020～2034年
  • 中東・アフリカ：エンドユーザー別、2020～2034年
  • サウジアラビア
  • アラブ首長国連邦
  • イスラエル
  • 南アフリカ
  • その他の中東・アフリカ
• ラテンアメリカ
  • ラテンアメリカ：方法別、2020～2034年
  • ラテンアメリカ：抗体タイプ別、2020～2034年
  • ラテンアメリカ：エンドユーザー別、2020～2034年
  • メキシコ
  • ブラジル
  • アルゼンチン
  • その他のラテンアメリカ

第9章 競合情勢

• 拡大と買収の分析
  • 拡大
  • 買収
• 提携/協業/合意/公開

第10章 企業プロファイル

• Biocytogen
• Charles River Laboratories
• Creative Biolabs
• Danaher Corporation
• Eurofins Scientific
• Evotec
• Fairjourney Biologics S.A
• Genscript Technology Corporation
• Sartorius AG
• Twist Bioscience

List of Tables:

• Table 1 Global Antibody Discovery Market, by Method, 2020-2034 (USD billion)
• Table 2 Global Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
• Table 3 Global Antibody Discovery Market, by End User, 2020-2034 (USD billion)
• Table 4 North America: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
• Table 5 North America: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
• Table 6 North America: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
• Table 7 U.S.: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
• Table 8 U.S.: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
• Table 9 U.S.: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
• Table 10 Canada: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
• Table 11 Canada: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
• Table 12 Canada: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
• Table 13 Europe: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
• Table 14 Europe: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
• Table 15 Europe: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
• Table 16 UK: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
• Table 17 UK: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
• Table 18 UK: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
• Table 19 France: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
• Table 20 France: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
• Table 21 France: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
• Table 22 Germany: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
• Table 23 Germany: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
• Table 24 Germany: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
• Table 25 Italy: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
• Table 26 Italy: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
• Table 27 Italy: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
• Table 28 Spain: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
• Table 29 Spain: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
• Table 30 Spain: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
• Table 31 Netherlands: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
• Table 32 Netherlands: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
• Table 33 Netherlands: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
• Table 34 Russia: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
• Table 35 Russia: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
• Table 36 Russia: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
• Table 37 Rest of Europe: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
• Table 38 Rest of Europe: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
• Table 39 Rest of Europe: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
• Table 40 Asia Pacific: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
• Table 41 Asia Pacific: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
• Table 42 Asia Pacific: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
• Table 43 China: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
• Table 44 China: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
• Table 45 China: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
• Table 46 India: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
• Table 47 India: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
• Table 48 India: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
• Table 49 Malaysia: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
• Table 50 Malaysia: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
• Table 51 Malaysia: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
• Table 52 Japan: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
• Table 53 Japan: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
• Table 54 Japan: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
• Table 55 Indonesia: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
• Table 56 Indonesia: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
• Table 57 Indonesia: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
• Table 58 South Korea: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
• Table 59 South Korea: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
• Table 60 South Korea: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
• Table 61 Australia: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
• Table 62 Australia: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
• Table 63 Australia: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
• Table 64 Rest of Asia Pacific: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
• Table 65 Rest of Asia Pacific: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
• Table 66 Rest of Asia Pacific: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
• Table 67 Middle East & Africa: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
• Table 68 Middle East & Africa: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
• Table 69 Middle East & Africa: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
• Table 70 Saudi Arabia: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
• Table 71 Saudi Arabia: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
• Table 72 Saudi Arabia: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
• Table 73 UAE: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
• Table 74 UAE: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
• Table 75 UAE: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
• Table 76 Israel: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
• Table 77 Israel: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
• Table 78 Israel: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
• Table 79 South Africa: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
• Table 80 South Africa: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
• Table 81 South Africa: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
• Table 82 Rest of Middle East & Africa: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
• Table 83 Rest of Middle East & Africa: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
• Table 84 Rest of Middle East & Africa: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
• Table 85 Latin America: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
• Table 86 Latin America: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
• Table 87 Latin America: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
• Table 88 Mexico: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
• Table 89 Mexico: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
• Table 90 Mexico: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
• Table 91 Brazil: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
• Table 92 Brazil: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
• Table 93 Brazil: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
• Table 94 Argentina: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
• Table 95 Argentina: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
• Table 96 Argentina: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
• Table 97 Rest of Latin America: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
• Table 98 Rest of Latin America: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
• Table 99 Rest of Latin America: Antibody Discovery Market, by End User, 2020-2034 (USD billion)

List of Figures:

• Figure 1. Global Antibody Discovery Market, 2020-2034 (USD billion)
• Figure 2. Integrated Ecosystem
• Figure 3. Research Methodology: Top-Down & Bottom-Up Price
• Figure 4. Market by Geography
• Figure 5. Porter's Five Forces
• Figure 6. Market by Method
• Figure 7. Global Antibody Discovery Market, by Method, 2024 & 2034 (USD billion)
• Figure 8. Market by Antibody Type
• Figure 9. Global Antibody Discovery Market, by Antibody Type, 2024 & 2034 (USD billion)
• Figure 10. Market by End User
• Figure 11. Global Antibody Discovery Market, by End User, 2024 & 2034 (USD billion)
• Figure 12. Global Antibody Discovery Market Assessment, By Geography, 2020-2034 (USD billion)
• Figure 13. Strategic Analysis - Global Antibody Discovery Market

The antibody discovery market size is expected to reach USD 20.41 billion by 2034, according to a new study by Polaris Market Research. The report "Antibody Discovery Market Size, Share, Trends, Industry Analysis Report By Method (Phage Display, Hybridoma, Other), By Antibody Type, By End User, By Region- Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Antibody discovery is the process of identifying and developing antibodies that can specifically bind to a target, such as a virus, bacterium, or cancer cell. It involves techniques such as hybridoma technology, phage display, or single B-cell screening to isolate and optimize effective antibodies. These antibodies are then characterized and tested for their potential use in diagnostics, therapeutics, or research.

Personalized medicine is transforming the way diseases are treated by focusing on therapies that are tailored to an individual's genetic makeup and condition. Antibodies play a key role in this approach as they can be engineered to target specific molecules in the body, such as those found in cancer cells. The demand for customized antibody therapies is rising as more people and doctors prefer treatments that are more precise and have fewer side effects. This shift is especially important in fields such as oncology, where no two patients respond exactly the same way to treatment. Antibody discovery technologies enable the identification and development of highly specific treatments tailored to different patient groups. This trend is encouraging pharmaceutical companies to invest more in research that supports personalized approaches. As awareness and success stories around personalized medicine grow, it pushes the antibody discovery market forward, making it an essential part of future healthcare.

Strategic collaborations between biotech companies, pharmaceutical giants, academic institutions, and research labs are playing a big role in advancing antibody discovery. These partnerships allow different organizations to share resources, knowledge, and technology, making the discovery process faster and more effective. A research lab may have an advanced technological setup, while a pharmaceutical company may have the funding and manufacturing capabilities. Collaborations further help in managing the high cost and risk associated with drug development. Many companies now enter co-development or licensing agreements to share profits and responsibilities. This trend has led to a growing number of antibody-related drugs entering clinical trials and eventually reaching patients.

Antibody Discovery Market Report Highlights

In 2024, the phage display segment dominated with the largest share due to its versatility, reliability, and ability to produce high-affinity antibodies in a relatively short time.

The pharmaceutical and biotechnology industry segment is expected to experience significant growth during the forecast period as these companies are increasingly focused on developing biologic drugs, including monoclonal antibodies, to treat a wide range of conditions such as cancer, autoimmune diseases, and infectious diseases.

In 2024, North America dominated the antibody discovery market with the largest share due to its strong biomedical research infrastructure and consistent investments in life sciences.

The Asia Pacific antibody discovery market is experiencing significant growth driven by expanding biotech industries, supportive government initiatives, and increasing investments in healthcare research.

A few global key market players are Biocytogen, Charles River Laboratories, Creative Biolabs, Danaher Corporation, Eurofins Scientific, Evotec, Fairjourney Biologics S.A, Genscript Technology Corporation, Sartorius AG, and Twist Bioscience.

Polaris Market Research has segmented the antibody discovery market report on the basis of method, antibody type, end user, and region:

By Method (Revenue - USD Billion, 2020-2034)

Phage Display

Hybridoma

Others

By Antibody Type (Revenue - USD Billion, 2020-2034)

Humanized Antibody

Human Antibody

Chimeric Antibody

Murine Antibody

By End User (Revenue - USD Billion, 2020-2034)

Pharmaceutical and Biotechnology industry

Research laboratory

Academic laboratory

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

U.S.

Canada

Mexico

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Antibody Discovery Market Insights

• 4.1. Antibody Discovery Market - Market Snapshot
• 4.2. Antibody Discovery Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Growing Prevalence of Chronic and Infectious Disease
    • 4.2.1.2. Increase in Investment in Biopharmaceutical R&D
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. High Initial Cost of Manufacturing
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. Antibody Discovery Market Trends
• 4.6. Value Chain Analysis

5. Global Antibody Discovery Market, by Method

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Antibody Discovery Market, by Method, 2020-2034 (USD billion)
• 5.3. Phage Display
  • 5.3.1. Global Antibody Discovery Market, by Phage Display, by Region, 2020-2034 (USD billion)
• 5.4. Hybridoma
  • 5.4.1. Global Antibody Discovery Market, by Hybridoma, by Region, 2020-2034 (USD billion)
• 5.5. Others
  • 5.5.1. Global Antibody Discovery Market, by Others, by Region, 2020-2034 (USD billion)

6. Global Antibody Discovery Market, by Antibody Type

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
• 6.3. Humanized Antibody
  • 6.3.1. Global Antibody Discovery Market, by Humanized Antibody, by Region, 2020-2034 (USD billion)
• 6.4. Human Antibody
  • 6.4.1. Global Antibody Discovery Market, by Human Antibody, by Region, 2020-2034 (USD billion)
• 6.5. Chimeric Antibody
  • 6.5.1. Global Antibody Discovery Market, by Chimeric Antibody, by Region, 2020-2034 (USD billion)
• 6.6. Murine Antibody
  • 6.6.1. Global Antibody Discovery Market, by Murine Antibody, by Region, 2020-2034 (USD billion)

7. Global Antibody Discovery Market, by End User

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Global Antibody Discovery Market, by End User, 2020-2034 (USD billion)
• 7.3. Pharmaceutical and Biotechnology industry
  • 7.3.1. Global Antibody Discovery Market, by Pharmaceutical and Biotechnology industry, by Region, 2020-2034 (USD billion)
• 7.4. Research laboratory
  • 7.4.1. Global Antibody Discovery Market, by Research laboratory, by Region, 2020-2034 (USD billion)
• 7.5. Academic laboratory
  • 7.5.1. Global Antibody Discovery Market, by Academic laboratory, by Region, 2020-2034 (USD billion)

8. Global Antibody Discovery Market, by Geography

• 8.1. Key Findings
• 8.2. Introduction
  • 8.2.1. Antibody Discovery Market Assessment, By Geography, 2020-2034 (USD billion)
• 8.3. Antibody Discovery Market - North America
  • 8.3.1. North America: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • 8.3.2. North America: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • 8.3.3. North America: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • 8.3.4. Antibody Discovery Market - U.S.
    • 8.3.4.1. U.S.: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
    • 8.3.4.2. U.S.: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
    • 8.3.4.3. U.S.: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • 8.3.5. Antibody Discovery Market - Canada
    • 8.3.5.1. Canada: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
    • 8.3.5.2. Canada: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
    • 8.3.5.3. Canada: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
• 8.4. Antibody Discovery Market - Europe
  • 8.4.1. Europe: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • 8.4.2. Europe: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • 8.4.3. Europe: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • 8.4.4. Antibody Discovery Market - UK
    • 8.4.4.1. UK: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
    • 8.4.4.2. UK: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
    • 8.4.4.3. UK: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • 8.4.5. Antibody Discovery Market - France
    • 8.4.5.1. France: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
    • 8.4.5.2. France: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
    • 8.4.5.3. France: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • 8.4.6. Antibody Discovery Market - Germany
    • 8.4.6.1. Germany: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
    • 8.4.6.2. Germany: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
    • 8.4.6.3. Germany: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • 8.4.7. Antibody Discovery Market - Italy
    • 8.4.7.1. Italy: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
    • 8.4.7.2. Italy: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
    • 8.4.7.3. Italy: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • 8.4.8. Antibody Discovery Market - Spain
    • 8.4.8.1. Spain: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
    • 8.4.8.2. Spain: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
    • 8.4.8.3. Spain: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • 8.4.9. Antibody Discovery Market - Netherlands
    • 8.4.9.1. Netherlands: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
    • 8.4.9.2. Netherlands: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
    • 8.4.9.3. Netherlands: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • 8.4.10. Antibody Discovery Market - Russia
    • 8.4.10.1. Russia: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
    • 8.4.10.2. Russia: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
    • 8.4.10.3. Russia: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • 8.4.11. Antibody Discovery Market - Rest of Europe
    • 8.4.11.1. Rest of Europe: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
    • 8.4.11.2. Rest of Europe: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
    • 8.4.11.3. Rest of Europe: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
• 8.5. Antibody Discovery Market - Asia Pacific
  • 8.5.1. Asia Pacific: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • 8.5.2. Asia Pacific: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • 8.5.3. Asia Pacific: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • 8.5.4. Antibody Discovery Market - China
    • 8.5.4.1. China: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
    • 8.5.4.2. China: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
    • 8.5.4.3. China: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • 8.5.5. Antibody Discovery Market - India
    • 8.5.5.1. India: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
    • 8.5.5.2. India: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
    • 8.5.5.3. India: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • 8.5.6. Antibody Discovery Market - Malaysia
    • 8.5.6.1. Malaysia: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
    • 8.5.6.2. Malaysia: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
    • 8.5.6.3. Malaysia: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • 8.5.7. Antibody Discovery Market - Japan
    • 8.5.7.1. Japan: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
    • 8.5.7.2. Japan: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
    • 8.5.7.3. Japan: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • 8.5.8. Antibody Discovery Market - Indonesia
    • 8.5.8.1. Indonesia: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
    • 8.5.8.2. Indonesia: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
    • 8.5.8.3. Indonesia: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • 8.5.9. Antibody Discovery Market - South Korea
    • 8.5.9.1. South Korea: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
    • 8.5.9.2. South Korea: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
    • 8.5.9.3. South Korea: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • 8.5.10. Antibody Discovery Market - Australia
    • 8.5.10.1. Australia: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
    • 8.5.10.2. Australia: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
    • 8.5.10.3. Australia: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • 8.5.11. Antibody Discovery Market - Rest of Asia Pacific
    • 8.5.11.1. Rest of Asia Pacific: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
    • 8.5.11.2. Rest of Asia Pacific: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
    • 8.5.11.3. Rest of Asia Pacific: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
• 8.6. Antibody Discovery Market - Middle East & Africa
  • 8.6.1. Middle East & Africa: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • 8.6.2. Middle East & Africa: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • 8.6.3. Middle East & Africa: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • 8.6.4. Antibody Discovery Market - Saudi Arabia
    • 8.6.4.1. Saudi Arabia: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
    • 8.6.4.2. Saudi Arabia: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
    • 8.6.4.3. Saudi Arabia: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • 8.6.5. Antibody Discovery Market - UAE
    • 8.6.5.1. UAE: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
    • 8.6.5.2. UAE: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
    • 8.6.5.3. UAE: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • 8.6.6. Antibody Discovery Market - Israel
    • 8.6.6.1. Israel: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
    • 8.6.6.2. Israel: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
    • 8.6.6.3. Israel: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • 8.6.7. Antibody Discovery Market - South Africa
    • 8.6.7.1. South Africa: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
    • 8.6.7.2. South Africa: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
    • 8.6.7.3. South Africa: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • 8.6.8. Antibody Discovery Market - Rest of Middle East & Africa
    • 8.6.8.1. Rest of Middle East & Africa: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
    • 8.6.8.2. Rest of Middle East & Africa: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
    • 8.6.8.3. Rest of Middle East & Africa: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
• 8.7. Antibody Discovery Market - Latin America
  • 8.7.1. Latin America: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • 8.7.2. Latin America: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • 8.7.3. Latin America: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • 8.7.4. Antibody Discovery Market - Mexico
    • 8.7.4.1. Mexico: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
    • 8.7.4.2. Mexico: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
    • 8.7.4.3. Mexico: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • 8.7.5. Antibody Discovery Market - Brazil
    • 8.7.5.1. Brazil: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
    • 8.7.5.2. Brazil: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
    • 8.7.5.3. Brazil: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • 8.7.6. Antibody Discovery Market - Argentina
    • 8.7.6.1. Argentina: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
    • 8.7.6.2. Argentina: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
    • 8.7.6.3. Argentina: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • 8.7.7. Antibody Discovery Market - Rest of Latin America
    • 8.7.7.1. Rest of Latin America: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
    • 8.7.7.2. Rest of Latin America: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
    • 8.7.7.3. Rest of Latin America: Antibody Discovery Market, by End User, 2020-2034 (USD billion)

9. Competitive Landscape

• 9.1. Expansion and Acquisition Analysis
  • 9.1.1. Expansion
  • 9.1.2. Acquisitions
• 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

• 10.1. Biocytogen
  • 10.1.1. Company Overview
  • 10.1.2. Financial Performance
  • 10.1.3. Method Benchmarking
  • 10.1.4. Recent Development
• 10.2. Charles River Laboratories
  • 10.2.1. Company Overview
  • 10.2.2. Financial Performance
  • 10.2.3. Method Benchmarking
  • 10.2.4. Recent Development
• 10.3. Creative Biolabs
  • 10.3.1. Company Overview
  • 10.3.2. Financial Performance
  • 10.3.3. Method Benchmarking
  • 10.3.4. Recent Development
• 10.4. Danaher Corporation
  • 10.4.1. Company Overview
  • 10.4.2. Financial Performance
  • 10.4.3. Method Benchmarking
  • 10.4.4. Recent Development
• 10.5. Eurofins Scientific
  • 10.5.1. Company Overview
  • 10.5.2. Financial Performance
  • 10.5.3. Method Benchmarking
  • 10.5.4. Recent Development
• 10.6. Evotec
  • 10.6.1. Company Overview
  • 10.6.2. Financial Performance
  • 10.6.3. Method Benchmarking
  • 10.6.4. Recent Development
• 10.7. Fairjourney Biologics S.A
  • 10.7.1. Company Overview
  • 10.7.2. Financial Performance
  • 10.7.3. Method Benchmarking
  • 10.7.4. Recent Development
• 10.8. Genscript Technology Corporation
  • 10.8.1. Company Overview
  • 10.8.2. Financial Performance
  • 10.8.3. Method Benchmarking
  • 10.8.4. Recent Development
• 10.9. Sartorius AG
  • 10.9.1. Company Overview
  • 10.9.2. Financial Performance
  • 10.9.3. Method Benchmarking
  • 10.9.4. Recent Development
• 10.10. Twist Bioscience
  • 10.10.1. Company Overview
  • 10.10.2. Financial Performance
  • 10.10.3. Method Benchmarking
  • 10.10.4. Recent Development